Literature DB >> 16687404

Dynamic positive feedback phosphorylation of mixed lineage kinase 3 by JNK reversibly regulates its distribution to Triton-soluble domains.

Karen A Schachter1, Yan Du, Anning Lin, Kathleen A Gallo.   

Abstract

MLK3 (mixed lineage kinase 3) is a widely expressed, mammalian serine/threonine protein kinase that activates multiple MAPK pathways. Previously our laboratory used in vivo labeling/mass spectrometry to identify phosphorylation sites of activated MLK3. Seven of 11 identified sites correspond to the consensus motif for phosphorylation by proline-directed kinases. Based on these results, we hypothesized that JNK, or another proline-directed kinase, phosphorylates MLK3 as part of a feedback loop. Herein we provide evidence that MLK3 can be phosphorylated by JNK in vitro and in vivo. Blockade of JNK results in dephosphorylation of MLK3. The hypophosphorylated form of MLK3 is inactive and redistributes to a Triton-insoluble fraction. Recovery from JNK inhibition restores MLK3 solubility and activity, indicating that the redistribution process is reversible. This work describes a novel mode of regulation of MLK3, by which JNK-mediated feedback phosphorylation of MLK3 regulates its activation and deactivation states by cycling between Triton-soluble and Triton-insoluble forms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687404     DOI: 10.1074/jbc.M603324200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Metabolic stress signaling mediated by mixed-lineage kinases.

Authors:  Anja Jaeschke; Roger J Davis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 2.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

3.  Who pulls the trigger: JNK activation in liver lipotoxicity?

Authors:  Samar H Ibrahim; Gregory J Gores
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

4.  Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.

Authors:  Manju Sharma; Fumihiko Urano; Anja Jaeschke
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

5.  Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells.

Authors:  Vidya Gadang; Eddy Konaniah; David Y Hui; Anja Jaeschke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-01       Impact factor: 8.311

Review 6.  Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?

Authors:  Matthew E Handley; Jane Rasaiyaah; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2007-04       Impact factor: 1.925

7.  MLK3 limits activated Galphaq signaling to Rho by binding to p63RhoGEF.

Authors:  Katherine I Swenson-Fields; Joshua C Sandquist; Jessica Rossol-Allison; Irene C Blat; Krister Wennerberg; Keith Burridge; Anthony R Means
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

8.  Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity.

Authors:  Manju Sharma; Vidya Gadang; Anja Jaeschke
Journal:  Mol Pharmacol       Date:  2012-08-23       Impact factor: 4.436

9.  Loss of MLK3 signaling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa.

Authors:  Pavlo L Kovalenko; Lyudmyla Kunovska; Jian Chen; Kathleen A Gallo; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-23       Impact factor: 4.052

10.  JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Justin L Mott; Nafisa A Elmi; Steven F Bronk; Nathan W Werneburg; Yuko Akazawa; Alisan Kahraman; Sean P Garrison; Gerard P Zambetti; Michael R Charlton; Gregory J Gores
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.